Daniel Marechal
Directeur/Membre du Conseil chez Targetome NV
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Eric Feller | M | - |
Targetome NV
 Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 14 ans |
| Joseph Martial | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 ans |
| Domenico Petta | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 ans |
| Francesco Fornieri | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 ans |
| John Kelly | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 9 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Denis Hermesse | M | 54 |
University of Liege
| 4 ans |
| Jean-Marc Gilson | M | 60 |
University of Liege
| 1 ans |
| François Camille Gilbert van Uffelen | M | - |
University of Liege
| 1 ans |
| Stephane Berghmans | M | 55 |
University of Liege
| 3 ans |
| Denis Goffaux | M | 57 |
University of Liege
| 4 ans |
| Valérie Gordenne | F | 51 |
University of Liege
| 4 ans |
| Emmanuel Lacroix | M | - |
University of Liege
| 5 ans |
| Jean-Pierre Verlaine | M | - |
University of Liege
| 2 ans |
| Philippe Kolh | M | - |
University of Liege
| 4 ans |
| Nikkolaos Antimissaris | M | 55 |
University of Liege
| 4 ans |
| Valérie Renard | M | - |
University of Liege
| 4 ans |
| Dimitri Liquet | M | - |
University of Liege
| 5 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Belgique | 17 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Daniel Marechal
- Réseau Personnel
